You have 1 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GSK2798745, efficacy, safety, chronic cough, crossover study

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Refractory Cough (CRC) With Non-atopic Asthma, CRC With Atopic Asthma, Unexplained Chronic Cough Trial (drug, other,

Not yet recruiting
  • Chronic Refractory Cough (CRC) With Non-atopic Asthma
  • +4 more
  • (no location specified)
Jan 9, 2023

Refractory Chronic Cough Trial (Nalbuphine Hydrochloride, Placebo)

Not yet recruiting
  • Refractory Chronic Cough
  • Nalbuphine Hydrochloride
  • Placebo
  • (no location specified)
Jul 18, 2023

Refractory Chronic Cough Trial (HRS-2261 oral tablet, Matching to HRS-2261)

Not yet recruiting
  • Refractory Chronic Cough
  • HRS-2261 oral tablet
  • Matching placebo to HRS-2261
  • (no location specified)
Feb 8, 2023

Chronic Cough Trial in United States (ADX-629, Placebo)

Recruiting
  • Chronic Cough
  • San Diego, California
  • +13 more
Sep 21, 2022

Cough Trial in United Kingdom (BAY1817080, Matching Placebo)

Completed
  • Cough
  • North Shields, Tyne And Wear, United Kingdom
  • +6 more
Jan 24, 2023

Long COVID-19 Syndrome Trial in Shenzhen (MSC-derived exosomes)

Recruiting
  • Long COVID-19 Syndrome
  • MSC-derived exosomes
  • Shenzhen, Guangdong, China
    Huazhong University of Science and Technology Union Shenzhen Hos
Apr 12, 2023

Refractory Chronic Cough Trial in United States (BLU-5937, Placebo)

Recruiting
  • Refractory Chronic Cough
  • Scottsdale, Arizona
  • +6 more
Oct 31, 2022

Cough Trial in United Kingdom (GSK2798745, Placebo)

Terminated
Has Results
  • Cough
  • Manchester, Lancashire, United Kingdom
  • +7 more
Sep 6, 2019

Pain Trial (GSK3858279, Placebo)

Not yet recruiting
  • Pain
  • (no location specified)
Apr 20, 2023

Nalbuphine, Idiopathic Pulmonary Fibrosis, Cough Trial in United Kingdom (Nalbuphine ER, Placebo oral tablet)

Completed
  • Nalbuphine
  • +2 more
  • Nalbuphine ER
  • Placebo oral tablet
  • Antrim, Northern Ireland, United Kingdom
  • +14 more
Oct 3, 2022

Refractory Chronic Cough Trial in United States (BLU-5937, Placebo)

Recruiting
  • Refractory Chronic Cough
  • Gulf Shores, Alabama
  • +30 more
Jan 23, 2023

Chronic Cough Trial in China (Gefapixant 45 mg twice daily (BID), Gefapixant 15 mg BID, Placebo)

Active, not recruiting
  • Chronic Cough
  • Gefapixant 45 mg twice daily (BID)
  • +2 more
  • Fuzhou, Fujian, China
  • +7 more
Jul 25, 2022

Chronic Hepatitis B Trial in Worldwide (Bepirovirsen, Placebo)

Recruiting
  • Chronic Hepatitis B
  • Victoria, British Columbia, Canada
  • +10 more
Jan 23, 2023

Chronic Hepatitis B Trial (Bepirovirsen, Placebo)

Recruiting
  • Chronic Hepatitis B
  • Herston, Queensland, Australia
  • +7 more
Jan 23, 2023

Hepatitis B, Chronic Trial in Worldwide (GSK3228836, GSK3528869A, Control)

Recruiting
  • Hepatitis B, Chronic
  • Edegem, Belgium
  • +47 more
Jan 24, 2023

Nasal Polyps Trial in China, Japan, Russian Federation (Mepolizumab, Placebo, Standard of care)

Active, not recruiting
  • Nasal Polyps
  • Dongguan, Guangdong, China
  • +60 more
Jan 10, 2023

Cough, Idiopathic Pulmonary Fibrosis Trial in Netherlands, United Kingdom, United States (Orvepitant Maleate, Placebo)

Recruiting
  • Cough
  • Idiopathic Pulmonary Fibrosis
  • Orvepitant Maleate
  • Placebo
  • Los Angeles, California
  • +28 more
Aug 16, 2022

Pulmonary Disease, Chronic Obstructive Trial (GSK3923868, Placebo)

Not yet recruiting
  • Pulmonary Disease, Chronic Obstructive
  • (no location specified)
May 26, 2022

Nasal Polyps Trial in Worldwide (Depemokimab (GSK3511294), Placebo)

Recruiting
  • Nasal Polyps
  • Depemokimab (GSK3511294)
  • Placebo
  • Tucson, Arizona
  • +79 more
Jan 19, 2023

Nasal Polyps Trial in Worldwide (Depemokimab (GSK3511294), Placebo)

Recruiting
  • Nasal Polyps
  • Depemokimab (GSK3511294)
  • Placebo
  • Roseville, California
  • +84 more
Jan 19, 2023

Hepatitis B, Chronic Trial in China (Tenofovir disoproxil fumarate)

Completed
Has Results
  • Hepatitis B, Chronic
  • Tenofovir disoproxil fumarate
  • Guangzhou, Guangdong, China
  • +18 more
Nov 26, 2021

Hepatitis B Trial in Worldwide (GSK3228836, PegIFN, NA therapy)

Active, not recruiting
  • Hepatitis B
  • Sacramento, California
  • +48 more
Jan 19, 2023

Autism Spectrum Disorder, Autism Trial in United States (L1-79)

Recruiting
  • Autism Spectrum Disorder
  • Autism
  • Phoenix, Arizona
  • +7 more
Jan 25, 2023

Hepatitis B, Chronic Trial in Worldwide (ChAd155-hIi-HBV low dose formulation, ChAd155-hIi-HBV high dose formulation,

Recruiting
  • Hepatitis B, Chronic
  • ChAd155-hIi-HBV low dose formulation
  • +6 more
  • Antwerpen, Belgium
  • +35 more
Jan 28, 2022

PTSD Trial in Phoenix (High THC cannabis, High CBD cannabis, THC/CBD cannabis)

Completed
Has Results
  • Posttraumatic Stress Disorder
  • High THC cannabis
  • +3 more
  • Phoenix, Arizona
    Scottsdale Research Institute
Jun 14, 2022